Financial reports
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
Current reports
8-K/A
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
28 Jul 23
8-K
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
24 Jul 23
8-K/A
Entry into a Material Definitive Agreement
13 Jul 23
8-K
Cost Associated with Exit or Disposal Activities
31 May 23
8-K
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
30 May 23
8-K
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
11 May 23
8-K
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
30 Mar 23
8-K
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
28 Mar 23
8-K
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
9 Mar 23
8-K
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
7 Mar 23
Registration and prospectus
15-12G
Securities registration termination
11 Aug 23
POS AM
Prospectus update (post-effective amendment)
24 Jul 23
POS AM
Prospectus update (post-effective amendment)
24 Jul 23
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jul 23
25-NSE
Exchange delisting
24 Jul 23
SC 13E3/A
Going private transaction (amended)
20 Jul 23
SC 14D9/A
Tender offer solicitation (amended)
20 Jul 23
SC TO-T/A
Third party tender offer statement (amended)
20 Jul 23
SC 13E3/A
Going private transaction (amended)
13 Jul 23
SC 14D9/A
Tender offer solicitation (amended)
13 Jul 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
26 Jul 23
EFFECT
Notice of effectiveness
26 Jul 23
EFFECT
Notice of effectiveness
31 Mar 23
EFFECT
Notice of effectiveness
6 Oct 22
CORRESP
Correspondence with SEC
4 Oct 22
UPLOAD
Letter from SEC
3 Oct 22
EFFECT
Notice of effectiveness
7 Apr 22
EFFECT
Notice of effectiveness
15 Feb 22
CORRESP
Correspondence with SEC
10 Feb 22
UPLOAD
Letter from SEC
9 Feb 22
Ownership
SC 13D/A
Boscolo Intervest Ltd
28 Jul 23
SC 13D/A
Insud Pharma S.L.
28 Jul 23
SC 13D/A
Builders Vision, LLC
27 Jul 23
4
Change in insider ownership
27 Jul 23
3
Initial statement of insider ownership
27 Jul 23
4
Dennis A. Clarke
27 Jul 23
4
Eric Senior Anderson
27 Jul 23
4
Change in insider ownership
27 Jul 23
SC 13D/A
KODIAK VENTURE PARTNERS III LP
26 Jul 23
4
CHARLES L COONEY
26 Jul 23